Skip to search
Skip to main content
Back to Search
Start Over
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment ofhigh-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNetStudy
Authors :
Baccarani, M Rosti, G Castagnetti, F Haznedaroglu, I Porkka, K Abruzzese, E Alimena, G Ehrencrona, H Hjorth Hansen, H Kairisto, V Levato, L Martinelli, G Nagler, A Lanng Nielsen, J Ozbek, U Palandri, F Palmieri, F Pane, F Rege Cambrin, G Russo, D Specchia, G Testoni, N Weiss Bjerrum, O Saglio, Giuseppe Simonsson, B.
Publication Year :
2009
Details
Language :
English
Database :
OpenAIRE
Accession number :
edsair.od.......970..71df77a55a5dd6d4d685086a98abb5f9